Market Approval of the Year

The Award

This award recognises the team that through excellence in strategy, process, patient focus and negotiation was able to successfully gain the market approval of a transformational new therapy, drug, diagnostic tool or medical device.

Judges paid particular attention to:

  • Targeting of unmet medical need/improvement on existing on-market drugs.
  • Market potential/size.
  • Speed/progress through late-stage clinical/development stages.
  • Key indicators/results/inflection points of development.
  • Outline of future timelines and geographic scale

Company Description  

Novartis is a healthcare company which strives to change the practice of medicine and aspires to approach things differently. We are passionate about what we do and the impact we have on patients and societies. We are Novartis, and we are re-imagining medicine.

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.